Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
And the Covid-19 list keeps growing...
01:12pm, Wednesday, 04'th Mar 2020
Recent announcements on the COVID-19 front:Luminex (NASDAQ:LMNX): Working on two SARS-Cov-2 tests: NxTAG CoV Expanded Panel: should be available to ship to customers in a few weeks. Testing in China t
Healthcare dominates premarket losers amidst coronavirus situation
02:23pm, Tuesday, 03'rd Mar 2020
Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NAS
NVAX, SGMO among premarket gainers
02:20pm, Friday, 28'th Feb 2020
Dynatronics (NASDAQ:DYNT) +224%.Altimmune (NASDAQ:ALT) +143% on completing first development milestone toward a single-dose intranasal COVID-19 vaccine.Allied Healthcare Products (NASDAQ:AHPI) +103%
WLL, SPEX, CODX and AIM among midday movers
06:00pm, Thursday, 27'th Feb 2020
Gainers: iBio (NYSEMKT:IBIO) +131%.GAIN Capital Holdings (NYSE:GCAP) +66%.Vaxart (NASDAQ:VXRT) +57%.Co-Diagnostics (NASDAQ:CODX) +55%.Vir Biotechnology (NASDAQ:VIR) +51%.Allied Healthcare Products (NA
NVAX, INO among premarket gainers
02:16pm, Thursday, 27'th Feb 2020
Allied Healthcare Products (NASDAQ:AHPI) +71%.GAIN Capital Holdings (NYSE:GCAP) +66% on Q4 results.Co-Diagnostics (NASDAQ:CODX) +66%.Alpha Pro Tech (NYSEMKT:APT) +48% after updating on orders.AIM Im
AIM ImmunoTech Joins with ChinaGoAbroad for an Ampligen China Entry Against COVID-19, the New SARS-like Coronavirus Disease Epidemic
11:30am, Thursday, 27'th Feb 2020
OCALA, FL / ACCESSWIRE / February 27, 2020 / AIM ImmunoTech (NYSE American: AIM, or the Company), an immuno-pharma company focused on the research and development of therapeutics to treat immune disor
TSLA, KR among premarket gainers
02:15pm, Tuesday, 18'th Feb 2020
Bellerophon Therapeutics (NASDAQ:BLPH) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hy
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic
11:30am, Tuesday, 18'th Feb 2020
OCALA, FL / ACCESSWIRE / February 18, 2020 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral disea
INO, CRSP among premarket gainers
02:14pm, Thursday, 13'th Feb 2020
CounterPath (NASDAQ:CPAH) +49% on securing five-year deal with Vodafone Fiji to extend superior quality voice services to consumers.Alpha Pro Tech (NYSEMKT:APT) +29% as orders surge for Alpha Pro Te
OCALA, FL / ACCESSWIRE / February 12, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral
94 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
AIM ImmunoTech Inc. (NYSE American: AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company’s efforts toward joining the global
OCALA, FL / ACCESSWIRE / February 11, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the c
OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancer
SDRL, FCEL among premarket gainers
02:17pm, Tuesday, 28'th Jan 2020
Ocean Bio-Chem (NASDAQ:OBCI) +80% as its subsidiary Star brite announces registered EPA product kills the Coronavirus.Happiness Biotech Group (NASDAQ:HAPP) +70% on sales of Cordyceps Mycelia product
